|
Human Growth HormonePublished by: AS Insights Published: Mar. 28, 2001 - 35 Pages Table of ContentsI. Executive Briefing II. State of the Science III. The Products IV. Current Market Situation V. Leading Companies & Their Products VI. Future Market Trends VII. Strategic Opportunities AbstractThe approval, by the FDA, of Pharmacia's Genotropin for the long-term treatment of growth failure in children with Prader-Willi syndrome (PWS) has revitalized the market for Human Growth Hormone which is expected to reach US$2.2 billion by 2006. Currently there are several windows of opportunities opening in the market for r-HGH and related products. Super generics, new molecules and novel technologies are just few of the many entry strategies available to companies wishing to participate in this important market.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||